AMRX
Amneal Pharmaceuticals, Inc.
19.80$
-0.2%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +66.9% | -103.2% | – | +257.5% | -16.7% | -93.7% | +1,031.5% | +41.3% | +10.0% | -122.0% | – | – | |
| – | -0.5% | -2.5% | +13.5% | -6.4% | +12.2% | -9.0% | -0.1% | -10.0% | -9.0% | -12.3% | +10.7% | – | |
| – | -10.7% | +12.5% | +0.0% | +5.8% | +1.4% | +0.7% | +14.0% | -0.7% | -0.2% | +7.5% | +17.9% | – | |
| – | – | -122.3% | – | – | -48.9% | -586.8% | – | – | – | – | – | – | |
| – | +135.2% | -37.6% | -45.8% | +93.5% | +11.4% | -20.6% | +44.6% | -43.2% | +186.8% | -67.9% | +228.9% | – | |
| – | +135.2% | -37.6% | -67.3% | +220.4% | -22.5% | +10.8% | +49.2% | -15.4% | +102.3% | -52.2% | +465.4% | – | |
| – | – | -454.7% | -97.8% | +22.0% | +99.5% | +5,491.5% | -99.1% | – | – | – | – | – | |
| – | – | – | – | – | -36.3% | -68.4% | -11.3% | – | -104.4% | +0.7% | – | – | |
| – | +16.5% | -77.0% | +51.5% | +163.2% | -33.7% | -36.0% | +6.4% | – | -117.0% | +464.0% | – | – | |
| – | – | -1,456.9% | – | – | +39.5% | -224.8% | – | +904.1% | -51.6% | -245.6% | – | – | |
| – | +53.3% | -123.2% | – | +318.1% | -21.5% | -111.5% | – | +80.4% | -15.7% | -148.9% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.